{"id":"https://openalex.org/W1998570747","doi":"https://doi.org/10.1161/01.hyp.21.6.1056","title":"Kidney is an important target for the antihypertensive action of an angiotensin II receptor antagonist in spontaneously hypertensive rats.","display_name":"Kidney is an important target for the antihypertensive action of an angiotensin II receptor antagonist in spontaneously hypertensive rats.","publication_year":1993,"publication_date":"1993-06-01","ids":{"openalex":"https://openalex.org/W1998570747","doi":"https://doi.org/10.1161/01.hyp.21.6.1056","mag":"1998570747","pmid":"https://pubmed.ncbi.nlm.nih.gov/8505092"},"language":"en","primary_location":{"id":"doi:10.1161/01.hyp.21.6.1056","doi":"https://doi.org/10.1161/01.hyp.21.6.1056","is_oa":true,"landing_page_url":"https://doi.org/10.1161/01.hyp.21.6.1056","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.21.6.1056","source":{"id":"https://openalex.org/S67880631","display_name":"Hypertension","issn_l":"0194-911X","issn":["0194-911X","1524-4563"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hypertension","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.21.6.1056","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109209756","display_name":"J M Wood","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J M Wood","raw_affiliation_strings":["Department of Cardiovascular Research, CIBA GEIGY Ltd., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Research, CIBA GEIGY Ltd., Basel, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076731728","display_name":"C Schnell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C R Schnell","raw_affiliation_strings":["Department of Cardiovascular Research, CIBA GEIGY Ltd., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Research, CIBA GEIGY Ltd., Basel, Switzerland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105530438","display_name":"Nigel R. Levens","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N R Levens","raw_affiliation_strings":["Department of Cardiovascular Research, CIBA GEIGY Ltd., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Research, CIBA GEIGY Ltd., Basel, Switzerland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.4365,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.92478554,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"21","issue":"6_pt_2","first_page":"1056","last_page":"1061"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/valsartan","display_name":"valsartan","score":0.9700000286102295},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9679999947547913},{"id":"https://openalex.org/keywords/angiotensin-ii","display_name":"angiotensin II","score":0.9319999814033508},{"id":"https://openalex.org/keywords/kidney","display_name":"kidney","score":0.6800000071525574},{"id":"https://openalex.org/keywords/spontaneously-hypertensive-rats","display_name":"spontaneously hypertensive rats","score":0.9110000133514404},{"id":"https://openalex.org/keywords/renin-angiotensin-system","display_name":"renin-angiotensin system","score":0.9269999861717224},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.6039999723434448},{"id":"https://openalex.org/keywords/nephrectomy","display_name":"nephrectomy","score":0.6269999742507935}],"concepts":[{"id":"https://openalex.org/C2777387769","wikidata":"https://www.wikidata.org/wiki/Q155472","display_name":"Valsartan","level":3,"score":0.8604788780212402},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.8343324661254883},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.710633397102356},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6639715433120728},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.646306037902832},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6352553367614746},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.614289402961731},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.5591781735420227},{"id":"https://openalex.org/C2780708007","wikidata":"https://www.wikidata.org/wiki/Q285044","display_name":"Angiotensin II receptor antagonist","level":5,"score":0.5488414168357849},{"id":"https://openalex.org/C2776634560","wikidata":"https://www.wikidata.org/wiki/Q707540","display_name":"Renal artery","level":3,"score":0.5226081013679504},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.45205894112586975},{"id":"https://openalex.org/C138976137","wikidata":"https://www.wikidata.org/wiki/Q7201790","display_name":"Plasma renin activity","level":4,"score":0.42686864733695984},{"id":"https://openalex.org/C104849204","wikidata":"https://www.wikidata.org/wiki/Q24778533","display_name":"Angiotensin receptor","level":4,"score":0.2978288233280182},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2051832377910614}],"mesh":[{"descriptor_ui":"D000068756","descriptor_name":"Valsartan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000804","descriptor_name":"Angiotensin II","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007267","descriptor_name":"Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011918","descriptor_name":"Rats, Inbred SHR","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D012083","descriptor_name":"Renin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1161/01.hyp.21.6.1056","doi":"https://doi.org/10.1161/01.hyp.21.6.1056","is_oa":true,"landing_page_url":"https://doi.org/10.1161/01.hyp.21.6.1056","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.21.6.1056","source":{"id":"https://openalex.org/S67880631","display_name":"Hypertension","issn_l":"0194-911X","issn":["0194-911X","1524-4563"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hypertension","raw_type":"journal-article"},{"id":"pmid:8505092","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8505092","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hypertension (Dallas, Tex. : 1979)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1161/01.hyp.21.6.1056","doi":"https://doi.org/10.1161/01.hyp.21.6.1056","is_oa":true,"landing_page_url":"https://doi.org/10.1161/01.hyp.21.6.1056","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.21.6.1056","source":{"id":"https://openalex.org/S67880631","display_name":"Hypertension","issn_l":"0194-911X","issn":["0194-911X","1524-4563"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hypertension","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1998570747.pdf","grobid_xml":"https://content.openalex.org/works/W1998570747.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W1969229328","https://openalex.org/W2007338962","https://openalex.org/W2044404050","https://openalex.org/W2046042395","https://openalex.org/W2049425017","https://openalex.org/W2057251024","https://openalex.org/W2061743585","https://openalex.org/W2071646815","https://openalex.org/W2092171289","https://openalex.org/W2101601744","https://openalex.org/W2154885779","https://openalex.org/W2159191197","https://openalex.org/W2261611449","https://openalex.org/W2271587609","https://openalex.org/W2346141501","https://openalex.org/W2397525242","https://openalex.org/W2409603318","https://openalex.org/W2415055536","https://openalex.org/W2418644578","https://openalex.org/W2419051058","https://openalex.org/W4290349939"],"related_works":["https://openalex.org/W2152978243","https://openalex.org/W2105174367","https://openalex.org/W2070534059","https://openalex.org/W2181978484","https://openalex.org/W2472463512","https://openalex.org/W2303848360","https://openalex.org/W2093223478","https://openalex.org/W2049425017","https://openalex.org/W2053171397","https://openalex.org/W2332892010"],"abstract_inverted_index":{"Inhibitors":[0],"of":[1,8,25,60,151,198,201,213,264],"the":[2,20,23,29,34,53,57,206,253,262],"renin-angiotensin":[3],"system":[4],"lower":[5],"blood":[6,36,84,88,120,127,161,165,192,218,266],"pressure":[7,37,85,121,162,193,267],"spontaneously":[9,39,67,269],"hypertensive":[10,40,68,270],"rats,":[11,41],"although":[12],"plasma":[13],"renin":[14],"is":[15],"not":[16],"elevated.":[17],"To":[18],"test":[19],"hypothesis":[21],"that":[22],"actions":[24],"angiotensin":[26,48,249],"II":[27,49,250],"within":[28,252],"kidney":[30,59,254],"may":[31],"contribute":[32],"to":[33,71,205,256],"high":[35,265],"in":[38,87,126,164,191,217,261,268],"we":[42],"infused":[43],"valsartan,":[44],"a":[45],"subtype":[46],"1":[47,129],"receptor":[50],"antagonist,":[51],"via":[52],"suprarenal":[54],"artery":[55],"into":[56],"right":[58],"conscious,":[61],"freely":[62],"moving,":[63],"unilaterally":[64],"nephrectomized":[65],"(left)":[66],"rats":[69],"(12":[70],"14":[72],"weeks":[73],"old).":[74],"Valsartan":[75],"(0.3":[76],"mg/kg":[77,243],"per":[78,244],"day":[79,245],"for":[80],"48":[81,109,148,186,239],"hours)":[82,110],"lowered":[83],"(change":[86,125,163,216],"pressure,":[89,128,166,219],"-7":[90],"+/-":[91,94,98,130,133,137,168,171,175,221,224,228],"3,":[92],"-19":[93],"4,":[95,134,225],"and":[96,108,135,147,173,185,226,238],"-26":[97],"4":[99],"mm":[100,139,177,230],"Hg,":[101,140,178,231],"n":[102,141,179,232],"=":[103,142,180,233],"11,":[104,181],"at":[105,144,182,235],"12,":[106,145,183,236],"24,":[107,146,184,237],"after":[111,122,195,210,241],"intrarenal":[112,196],"administration":[113,124,197,212],"but":[114],"had":[115,156],"no":[116,157],"significant":[117,158],"effect":[118,159],"on":[119,160],"intravenous":[123,211],"5,":[131,169,222],"-3":[132],"10":[136],"5":[138,229],"7,":[143,234],"hours).":[149,187],"Infusion":[150],"vehicle":[152],"(0.9%":[153],"saline)":[154],"intrarenally":[155],"2":[167],"-1":[170],"6,":[172],"0":[174],"7":[176],"The":[188],"maximum":[189,207],"fall":[190,208],"reached":[194],"this":[199],"dose":[200],"valsartan":[202],"was":[203],"similar":[204],"induced":[209],"higher":[214],"doses":[215],"-14":[220],"-27":[223],"-32":[227],"hours":[240],"3":[242],"i.v.).":[246],"Thus,":[247],"endogenous":[248],"acting":[251],"appears":[255],"play":[257],"an":[258],"important":[259],"role":[260],"maintenance":[263],"rats.":[271]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}